PER 0.00% 10.0¢ percheron therapeutics limited

Ann: Antisense Therapeutics appoints new Non-Executive Director, page-35

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 254 Posts.
    lightbulb Created with Sketch. 38
    I have already raided this. One read is that CG has enough CSL shares and there is a likelihood CSL will invest in ANP. and what we are seeing is part of the long term plan by ANP/ CSL. One scenario.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.